Detalhe da pesquisa
1.
Society of Critical Care Medicine Guidelines on Glycemic Control for Critically Ill Children and Adults 2024.
Crit Care Med
; 52(4): e161-e181, 2024 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240484
2.
Cardio-renal-metabolic disease in primary care setting.
Diabetes Metab Res Rev
; 40(3): e3755, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38115715
3.
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.
N Engl J Med
; 382(26): 2493-2503, 2020 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32579810
4.
Gaps in our knowledge of managing inpatient dysglycaemia and diabetes in non-critically ill adults: A call for further research.
Diabet Med
; 40(3): e14980, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36256494
5.
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease.
Diabetes Obes Metab
; 25(6): 1646-1657, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36782093
6.
Relationship between body weight change and glycaemic control with tirzepatide treatment in people with type 2 diabetes: A post hoc assessment of the SURPASS clinical trial programme.
Diabetes Obes Metab
; 25(9): 2553-2560, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246796
7.
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use.
Diabetes Obes Metab
; 25(2): 407-416, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36193847
8.
Diabetic Ketoacidosis and Long-term Insulin Requirements in Youths with Newly Diagnosed Type 2 Diabetes During the SARS-CoV-2 Pandemic.
Endocr Pract
; 29(10): 754-761, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451650
9.
American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update.
Endocr Pract
; 29(5): 305-340, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37150579
10.
Relative Hypoglycemia and Lower Hemoglobin A1c-Adjusted Time in Band Are Strongly Associated With Increased Mortality in Critically Ill Patients.
Crit Care Med
; 50(8): e664-e673, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35132022
11.
Safety and Efficacy of Inpatient Diabetes Management with Non-insulin Agents: an Overview of International Practices.
Curr Diab Rep
; 22(6): 237-246, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507117
12.
Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.
Nephrol Dial Transplant
; 37(7): 1261-1269, 2022 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34850173
13.
Examining the evidence for weight management in individuals with type 2 diabetes.
Diabetes Obes Metab
; 24(8): 1411-1422, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545861
14.
Degludec hospital trial: A randomized controlled trial comparing insulin degludec U100 and glargine U100 for the inpatient management of patients with type 2 diabetes.
Diabetes Obes Metab
; 24(1): 42-49, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34490700
15.
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.
Endocr Pract
; 28(10): 923-1049, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35963508
16.
Glucose Control in the ICU.
N Engl J Med
; 389(13): 1234-1237, 2023 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37754290
17.
Diabetes Complications in Racial and Ethnic Minority Populations in the USA.
Curr Diab Rep
; 21(1): 2, 2021 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33420878
18.
Implementation of App-Based Diabetes Medication Management: Outpatient and Perioperative Clinical Decision Support.
Curr Diab Rep
; 21(12): 50, 2021 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902056
19.
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and severe renal impairment.
Diabetes Obes Metab
; 23(12): 2632-2642, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34338408
20.
Liraglutide hospital discharge trial: A randomized controlled trial comparing the safety and efficacy of liraglutide versus insulin glargine for the management of patients with type 2 diabetes after hospital discharge.
Diabetes Obes Metab
; 23(6): 1351-1360, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33591621